China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The effects of nutritional support combined with rehabilitation therapy on patients wi... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Improving Pathogen Detection Efficiency in Peritoneal Dialysis-Associated Peritonitis ... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy of Sivelestat Sodium in the Treatment of Sepsis Patients with ... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the Construction of a Fetal Position Visualization and Left/Right Identifi... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'OSCC serum biomarker'. The following are the other relevant details related to the tri... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase II, Single-Arm, Single-Center Clinical Trial of Vebreltinib Enteric Capsules i... Read More
China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on Key Technologies for Intelligent Precision Radiotherapy of Brain and Liver... Read More
Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or ... Read More
Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'An Interventional, Open-Label, Phase 2 Study to Investigate the Safety and Efficacy of PF-0863440... Read More
Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the e... Read More